FASI-10: Emerging Therapies & Diagnostics in Eosinophilic Esophagitis
Session 4 from the FASI-10 Summit on October 7th, 2026 featuring
Session 4 from the FASI-10 Summit on October 7th, 2026 featuring
FASI-supported research published in Cell traces the effect to L-carnitine, a nutrient abundant in red meat, and points to a potential drug target Key Findings: CAMBRIDGE, Mass. (Oct. 19, 2026) – Researchers at Yale School…
Ambition to Seed Drug Development Pipeline with Promising Targets Builds Off $10 Million in Initial Funding for Accelerator. CAMBRIDGE, MA. – The Food Allergy Science Initiative (FASI) marked its 10th anniversary by launching the Food…
Collaboration Brings High-Quality Materials and Specialized Capabilities to Drug Discovery Pipeline CAMBRIDGE, Mass. – The Food Allergy Science Initiative (FASI) and InBio announced today a partnership that will help accelerate the future of food allergy research….
By Dr. Christine Olsen Cases of Alpha Gal Syndrome (AGS) are exploding around the country, with the Hamptons as an epicenter, according to the Centers for Disease Control and Prevention. There were more than 3,700…
By Carlos Bosques, Ph.D. I read with great interest Michael J. Coren’s Sept. 9 Health column, “Schools should stop banning peanuts. Here’s what really keeps kids safe,” on evolving school-based strategies for managing peanut and…
Yale Professor and Food Allergy Science Initiative Principal Investigator Finds Possible Link Between Breast Milk Bacteria and Increased Immune Defenses
The Food Allergy Science Initiative (FASI) today announced that it has joined Vie Ventures as a strategic collaborator.
A discussion with experts in the field about clinical trials that are shaping the future of food allergies. Guest, Dr. Gideon Lack from King’s College London, who will be discussing about his transformative work on the impact of early allergen introduction.
Dr. David Golden discusses the development of sublingual epinephrine products.
The Food Allergy Science Initiative (FASI) is proud to congratulate Stephen D. Liberles, Ph.D., on his election to the National Academy of Sciences. This recognition is one of the highest honors a scientist can receive.
BOSTON–Physician-scientist Dr. Qian Yuan is taking on one of the most ambitious endurance challenges in distance running: completing all seven World Marathon Majors in a single year. He will be running Boston to raise awareness…
Join Our Email List